Pharmacological inhibition of PCSK9 (proprotein convertase subtilisin/kexin type nove) is an established therapeutic option to treat hypercholesterolemia, and plasma PCSK9 levels have been implicated in cardiovascular disease incidence. This study aimed to perform a systematic review and meta-analysis of randomized trials investigating the effect of continuous positive airway pressure... https://mrciobittencourtempresrio65149.tokka-blog.com/7702802/fatos-sobre-marcio-bittencourt-revelado